BACKGROUND: HIV-positive men with a history of anal-receptive intercourse are at risk for anal cancer. We determined whether human papilloma virus (HPV) biomarkers were correlated with anal pathology in these men. METHODS: HPV genotype was determined by PCR/line blot assay. Real-time PCR assays were done for viral load, E6 transcripts for HPV genotypes 16, 18, and 31, and p16 transcripts. RESULTS: The most common oncogenic HPV types were HPV 16 (38%), 18 (19%), 45 (22%), and 52 (19%). HPV types 16, 18, 31, 52, 59, and 68 were associated with high-grade histology. The number of HPV genotypes per anal swab was higher for anal intraepithelial neoplasia (AIN) 2/3 than for normal or AIN 1 histology [median, 5 types (interquartile range) (IQR), 3-7 versus 3.5 (IQR), 2-6; P = 0.0005]. HPV 16 viral load was also associated with AIN 2/3 histology. There was no difference in p16 or E6 transcripts between histologic grades. In the multivariable logistic regression model, HPV genotypes 16 [odds ratio, 2.58; 95% confidence interval (95% CI), 1.31-5.08; P = 0.006] and 31 (odds ratio, 4.74; 95% CI, 2.00-11.22; P = 0.0004), baseline CD4 count < 400 cells/mm(3) (odds ratio, 2.96; 95% CI, 1.46-5.99; P = 0.0025), and Acquired Immunodeficiency Syndrome (AIDS)-defining illness (odds ratio, 2.42; 95% CI, 1.22-4.82; P = 0.01) were associated with high-grade histology after adjusting for age. CONCLUSIONS: The presence of high-grade anal pathology (AIN 2/3) in HIV-positive men was associated with multiple HPV genotypes, HPV genotypes 16 and 31, and HPV 16 viral load.
BACKGROUND: HIV-positive men with a history of anal-receptive intercourse are at risk for anal cancer. We determined whether human papilloma virus (HPV) biomarkers were correlated with anal pathology in these men. METHODS:HPV genotype was determined by PCR/line blot assay. Real-time PCR assays were done for viral load, E6 transcripts for HPV genotypes 16, 18, and 31, and p16 transcripts. RESULTS: The most common oncogenic HPV types were HPV 16 (38%), 18 (19%), 45 (22%), and 52 (19%). HPV types 16, 18, 31, 52, 59, and 68 were associated with high-grade histology. The number of HPV genotypes per anal swab was higher for anal intraepithelial neoplasia (AIN) 2/3 than for normal or AIN 1 histology [median, 5 types (interquartile range) (IQR), 3-7 versus 3.5 (IQR), 2-6; P = 0.0005]. HPV 16 viral load was also associated with AIN 2/3 histology. There was no difference in p16 or E6 transcripts between histologic grades. In the multivariable logistic regression model, HPV genotypes 16 [odds ratio, 2.58; 95% confidence interval (95% CI), 1.31-5.08; P = 0.006] and 31 (odds ratio, 4.74; 95% CI, 2.00-11.22; P = 0.0004), baseline CD4 count < 400 cells/mm(3) (odds ratio, 2.96; 95% CI, 1.46-5.99; P = 0.0025), and Acquired Immunodeficiency Syndrome (AIDS)-defining illness (odds ratio, 2.42; 95% CI, 1.22-4.82; P = 0.01) were associated with high-grade histology after adjusting for age. CONCLUSIONS: The presence of high-grade anal pathology (AIN 2/3) in HIV-positive men was associated with multiple HPV genotypes, HPV genotypes 16 and 31, and HPV 16 viral load.
Authors: Andrea N Burnett-Hartman; Polly A Newcomb; Margaret T Mandelson; Denise A Galloway; Margaret M Madeleine; Michelle A Wurscher; Joseph J Carter; Karen W Makar; John D Potter; Stephen M Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-08-04 Impact factor: 4.254
Authors: Cristovam Scapulatempo-Neto; Carlos Veo; José Humberto T G Fregnani; Adriana Lorenzi; Allini Mafra; Armando G F Melani; Edgar Antonio Alemán Loaiza; Luciana Albina Reis Rosa; Cristina Mendes de Oliveira; José Eduardo Levi; Adhemar Longatto-Filho Journal: Oncol Lett Date: 2017-01-25 Impact factor: 2.967
Authors: Kenneth O Simbiri; Masanao Murakami; Michael Feldman; Andrew P Steenhoff; Oathokwa Nkomazana; Gregory Bisson; Erle S Robertson Journal: Infect Agent Cancer Date: 2010-03-26 Impact factor: 2.965
Authors: Philip E Castle; Stephen Follansbee; Sylvia Borgonovo; Diane Tokugawa; Lauren M Schwartz; Thomas S Lorey; Brandon LaMere; Julia C Gage; Barbara Fetterman; Teresa M Darragh; Ana Cecilia Rodriguez; Nicolas Wentzensen Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-15 Impact factor: 4.254
Authors: Edgar P Simard; Meg Watson; Mona Saraiya; Christina A Clarke; Joel M Palefsky; Ahmedin Jemal Journal: Cancer Date: 2013-07-16 Impact factor: 6.860
Authors: Lois J Conley; Timothy J Bush; Teresa M Darragh; Joel M Palefsky; Elizabeth R Unger; Pragna Patel; Martin Steinau; E Milu Kojic; Harold Martin; E Turner Overton; Susan Cu-Uvin; John Hammer; Keith Henry; Kathleen Wood; John T Brooks Journal: J Infect Dis Date: 2015-08-12 Impact factor: 5.226